Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Wild Bioscience Ltd. maintains 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This prosecution activity is confined to a single distinct art unit and involves a single distinct examiner. The narrow scope of the art unit indicates a specialized focus for the current pending matter. Having only a single pending office action allows for a highly concentrated effort on this specific application within the Biotechnology & Pharmaceuticals field.
SHEN, YANXIN NMN is the busiest examiner with 1 pending office action under their supervision. Since there is only a single pending office action in total, this examiner manages the entire active portfolio. This relationship between the examiner and the pending action simplifies the communication requirements for this portfolio. The presence of a single distinct examiner and a single distinct art unit means that the company's current patent office interaction is limited to a single point of review.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHEN, YANXIN NMN | 1 | 90.0% | +22.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19145241 | CARBON SEQUESTRATION WITH TRANSGENIC PLANTS EXPRESSING CARBONIC ANHYDRASE | SHEN, YANXIN NMN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19145241 | CARBON SEQUESTRATION WITH TRANSGENIC PLANTS EXPRESSING CARBONIC ANHYDRASE | SHEN, YANXIN NMN | — |
| Art Unit | Apps |
|---|---|
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19145241 | CARBON SEQUESTRATION WITH TRANSGENIC PLANTS EXPRESSING CARBONIC ANHYDRASE | SHEN, YANXIN NMN | 1663 | §103§112 | Non-Final OA | — | Pending | Jul 02, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial